Glioblastoma multiforme (GBM) is one of the most aggressive brain tumors, with the average 5-year survival rate being less than 10% with aggressive treatment.1 Treatment often includes surgery, radiation, chemotherapy, and steroids1. Researchers are currently investiga...
In 2011, the VHA Office of Healthcare Transformation launched Scan Echo, a telementoring program for primary care providers and PACT team staff. The VA Medical Center at West Haven, Connecticut was selected as one of seven hub sites across the US, on the basis of a com...
On November 6, 2017, Fresenius Kabi USA, LLC received FDA approval for its product, BORTEZOMIB for Injection. BORTEZOMIB for injection is indicated for the treatment of patients with multiple myeloma and the treatment of patients with mantle cell lymphoma who have rece...
Click here for this look into the importance of exercise during and after cancer treatment by Katherine Petersen, MS, RD, CNSC of the Phoenix VA Healthcare System.
VA-PALS (Veterans Affairs Partnership to Increase Access to Lung Screening) recently launched to improve early detection of lung cancer among Veterans. Please click here for more information. The Partnership also hosted a Lung Screening Summit in January.
I hope this message finds you all recovered from the holiday seasons, and eagerly awaiting springs arrival and winters departure! Mother nature has been rather “angry” this year, hasn’t she? We wanted to give you an update, your AVAHO Board has...
